Experimental diabetes induced by alloxan and streptozotocin: The current state of the art

M Radenković, M Stojanović, M Prostran - Journal of pharmacological and …, 2016 - Elsevier
Diabetes mellitus is a chronic metabolic disorder with a high prevalence worldwide. Animal
models of diabetes represent an important tool in diabetes investigation that helps us to …

Bile acid‐based advanced drug delivery systems, bilosomes and micelles as novel carriers for therapeutics

M Nemati, A Fathi‐Azarbayjani… - Cell Biochemistry …, 2022 - Wiley Online Library
Diabetes mellitus affects almost half a billion patients worldwide and results from either
destruction of β‐cells responsible for insulin secretion or increased tissue resistance to …

[HTML][HTML] Ileal bile acid transporter inhibition for the treatment of chronic constipation, cholestatic pruritus, and NASH

S Al-Dury, HU Marschall - Frontiers in pharmacology, 2018 - frontiersin.org
Bile acids are synthesized from cholesterol in the liver, excreted with bile into the duodenum,
almost completely taken up again in the distal ileum and finally returned to the liver with …

Semisynthetic bile acids: a new therapeutic option for metabolic syndrome

S Lazarević, M Đanić, S Goločorbin-Kon… - Pharmacological …, 2019 - Elsevier
Bile acids are endogenous emulsifiers synthesized from cholesterol having a peculiar
amphiphilic structure. Appreciation of their beneficial effects on human health, recognized …

Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study

A Mooranian, S Raj Wagle, B Kovacevic, R Takechi… - Scientific Reports, 2020 - nature.com
The antilipidemic drug, probucol (PB), has demonstrated potential applications in Type 2
diabetes (T2D) through its protective effects on pancreatic β-cells. PB has poor solubility and …

Stability and release kinetics of an advanced gliclazide-cholic acid formulation: the use of artificial-cell microencapsulation in slow release targeted oral delivery of …

A Mooranian, R Negrulj, S Mathavan, J Martinez… - Journal of …, 2014 - Springer
Introduction In previous studies carried out in our laboratory, a bile acid (BA) formulation
exerted a hypoglycaemic effect in a rat model of type-1 diabetes (T1D). When the …

Protective effects of beta glucan and gliclazide on brain tissue and sciatic nerve of diabetic rats induced by streptozosin

H Alp, S Varol, MM Celik, M Altas… - Journal of Diabetes …, 2012 - Wiley Online Library
There have not been yet enough studies about effects of beta glucan and gliclazide on
oxidative stress created by streptozotocin in the brain and sciatic nerve of diabetic rats. The …

In VitroIn Vivo Correlation for Gliclazide Immediate-Release Tablets Based on Mechanistic Absorption Simulation

S Grbic, J Parojcic, S Ibric, Z Djuric - Aaps Pharmscitech, 2011 - Springer
The aim of this study was to develop a drug-specific absorption model for gliclazide (GLK)
using mechanistic gastrointestinal simulation technology (GIST) implemented in GastroPlus …

The biological effects of the hypolipidaemic drug probucol microcapsules fed daily for 4 weeks, to an insulin-resistant mouse model: potential hypoglycaemic and anti …

A Mooranian, R Negrulj, R Takechi, J Mamo… - Drug delivery and …, 2018 - Springer
Probucol (PB) is an hypolipidaemic drug with potential antidiabetic effects. We showed
recently using in vitro studies that when PB was incorporated with stabilising lipophilic bile …

Deoxycholic acid as a modifier of the permeation of gliclazide through the blood brain barrier of a rat

M Lalić-Popović, V Vasović, B Milijašević… - Journal of diabetes …, 2013 - Wiley Online Library
Major problem for diabetic patients represents damage of blood vessels and the oxidative
stress of the brain cells due to increased concentration of free radicals and poor nutrition of …